Home › Funds › Eversept Partners, LP › COGT
Eversept Partners, LP position in COGT
COGENT BIOSCIENCES INC · Health Care
Eversept Partners, LP reported holding 480,111 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$15.4M, representing 0.83% of its reported portfolio and ranking #33 among its reported holdings. Eversept Partners, LP has disclosed COGT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Eversept Partners, LP's COGT position evolved
Eversept Partners, LP first disclosed a stake in COGT in Q2 2026 at 490,235 shares (US$19.0M). Across 2 filings, Eversept Partners, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 480,111 shares valued at US$15.4M — a reduction of -10,124 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 490.24K | $18.97M | New |
| Q3 2026 | 480.11K | $15.37M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COGT and 13F data
COGT (COGENT BIOSCIENCES INC) is a Health Care company. 49 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), Kynam Capital Management, LP (US$121.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- Fairmount Funds Management LLC 5.50M sh · $212.98M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.01M sh · $193.74M · Q2 2026
- Kynam Capital Management, LP 3.79M sh · $121.43M · Q3 2026
- Commodore Capital LP 3.05M sh · $118.03M · Q2 2026
- Octagon Capital Advisors LP 2.35M sh · $90.94M · Q2 2026
- TCG Crossover Management, LLC 2.50M sh · $80.05M · Q3 2026
- Deep Track Capital, LP 2.50M sh · $80.05M · Q3 2026
- RTW INVESTMENTS, LP 2.31M sh · $73.93M · Q3 2026
- Venrock Adviser, LLC 1.64M sh · $63.55M · Q2 2026
- EMERALD ADVISERS, LLC 1.61M sh · $51.67M · Q3 2026
- Siren, L.L.C. 1.61M sh · $51.53M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.57M sh · $50.42M · Q3 2026
More on Eversept Partners, LP
FAQ
How long has Eversept Partners, LP held COGT?
Eversept Partners, LP has disclosed COGT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Eversept Partners, LP's current position in COGT?
As of Q3 2026, Eversept Partners, LP holds 480.11K shares of COGT (COGENT BIOSCIENCES INC), valued at $15.37M, representing 0.83% of its reported portfolio and ranking #33.
Has Eversept Partners, LP been buying or selling COGT?
In the latest 13F filing (Q3 2026), Eversept Partners, LP reduced its position in COGT.
Which other funds hold COGT?
Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., Kynam Capital Management, LP, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.